Oruka Therapeutics, Inc. · NASDAQ:ORKA
Dambkowski Carl sold 105,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded May 21, 2026 · Filed May 22, 2026
On May 21, 2026, Dambkowski Carl (Director) sold 105,000 Oruka Therapeutics, Inc. shares at an average US$58.97 for US$6.19M under a trading plan, leaving 73,743 shares. Filed May 22, 2026 (Form 4).
- Sold
- 105,000 shares
- Price
- US$58.97 average (US$58.43 to US$59.97)
- Value
- US$6.19M
- Holding after
- 73,743 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | Option exercise | 38,689 | US$6.84 | 155,172 | Direct |
| May 21, 2026 | Common Stock | Option exercise | 11,904 | US$7.80 | 167,076 | Direct |
| May 21, 2026 | Common Stock | Option exercise | 11,667 | US$11.77 | 178,743 | Direct |
| May 21, 2026 | Common Stock | Sale | 38,318 | US$58.43 | 140,425 | Direct |
| May 21, 2026 | Common Stock | Sale | 53,447 | US$59.10 | 86,978 | Direct |
| May 21, 2026 | Common Stock | Sale | 13,235 | US$59.97 | 73,743 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Dambkowski Carl
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Dambkowski Carl · Jun 12, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026